Quick Facts

Dr. Marty Ross, MD
Dr. Ross's Expert Review
Cryptolepis sanguinolenta is a West African herb with a long history in traditional herbal medicine. When someone in my practice needs broad immune system support, especially within the herbal immune-support protocols I use, cryptolepis is one of the first herbs I think of. It is one of the herbs I trust most in my toolkit.
The studied side of cryptolepis is encouraging but limited. Test tube research shows the herb, and its main alkaloid cryptolepine, has strong activity against Babesia species, and laboratory work also shows activity against growing and persister forms of Borrelia and Bartonella. A 2023 review of natural bioactive nutraceuticals in tick-borne illness places cryptolepis near the top of the herbal options. These are lab findings, not human trials.
Safety data are limited too. Available toxicology work suggests the herb is generally well tolerated at commonly used amounts, though the same papers flag that anti-fertility and embryo effects have not been fully worked out. That fits with the standard warning to avoid it during pregnancy and nursing.
In my practice I use the 4 oz BioPure tincture as an ongoing support herb within a broader regimen rather than a stand-alone support. The liquid form makes it easy to start low, find a tolerable dose, and adjust as things change. Like most tinctures in this class, it can upset the stomach in some people. Diluting it in water or juice usually solves that.
I do not use cryptolepis in someone who is pregnant or nursing.
How I Use It in My Practice
I use cryptolepis most often as an ongoing support herb inside a full herbal regimen. The dose depends on the situation and is always set with the person’s physician. My usual range works up from 2.5 ml three times a day to 5 ml three times a day when more ongoing support is the goal. I start low and increase the amount over days as tolerated. I pair it with the other steps in my protocol rather than leaning on it alone. I do not use it in pregnancy or nursing.
The Research, in Dr. Ross's Words
In my read of this research, cryptolepis has one of the better laboratory records among the herbal options in this category. In a published test tube study, Cryptolepis sanguinolenta showed potent inhibitory activity against Babesia duncani, with no regrowth after subculture, and the same work showed good activity against Borrelia burgdorferi. A separate study of cryptolepine, the herb’s major alkaloid, found growth inhibition across several Babesia species and Theileria equi, which suggests the activity is not limited to one organism. A 2023 review of natural bioactive nutraceuticals in tick-borne illness reaches a similar conclusion, noting strong in vitro inhibitory activity against Borrelia and other tick-borne pathogens, including Babesia and Bartonella. The paper also indicates activity against growing and persister germ states. However the research has limits because there are no human studies. On safety, toxicology data suggest the herb is generally well tolerated at amounts under 500 mg per kg of body weight in animal models, but the same authors note that potential anti-fertility and embryotoxic effects have not been adequately studied. That gap lines up with the standard caution against use in pregnancy and nursing.
References
Supplement Facts
| Amount Per Serving | Amount | |
|---|---|---|
Cryptolepis sanguinolenta (root) extract | 1 mL | |






